ST500

ST500

Trauma

Information

ST500 is intended to limit the physiological degeneration of tendons and ligaments, thereby aiding joint movement. It is the future of tissue regeneration, a unique non-invasive formulation designed to accelerate tissue recovery, setting a new standard in regenerative treatments, with a remarkable improvement of clinical outcomes as well as reduction of tendon effusions and lesions.
Contrad Swiss SAS11.C119Contrad Swiss is a life sciences company advancing non-invasive solutions in musculoskeletal and aesthetic regenerative medicine. Our core is SIGMOLECS, a proprietary technology combining peptides with hyaluronic acid, acting directly at the site of application. Our portfolio includes medical devices for orthopaedics, sports medicine, rheumatology, pain therapy and rehabilitation, and solutions for aesthetic medicine offering quick post-procedure recovery and long-term optimization of skin’s regenerative capacity. All products for medical promotion are made in EU/Swiss facilities. 

Log in

See all the content and easy-to-use features by logging in or registering!